LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials

(2021) Emily Herrett et al.   BMJ-British Medical Journal

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

(2021) Antonio J. Vallejo-Vaz et al.   LANCET

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia

(2021) Natalia Ryzhaya et al.   Journal of the American Heart Association

Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia

(2021) Marianne Klevmoen et al.   ATHEROSCLEROSIS

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

(2021) Christos V. Rizos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry

(2020) Christos V. Rizos et al.   Lipids in Health and Disease

Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care

(2020) Sujana Balla et al.   Current Atherosclerosis Reports

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records

(2020) Barbara Iyen et al.   ATHEROSCLEROSIS

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects

(2020) Frances A. Wood et al.   NEW ENGLAND JOURNAL OF MEDICINE

LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia

(2019) Martin P. Bogsrud et al.   Journal of Clinical Lipidology

Moving Targets

(2019) Lars E. Larsen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Sex Differences in the Use of Statins in Community Practice

(2019) Michael G. Nanna et al.  

Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes

(2019) Kelly D. Myers et al.  

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

(2018) Liv J Mundal et al.   HEART

Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH

(2018) Kirsten B. Holven et al.   Journal of Clinical Lipidology

LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C

(2018) Xander M. van Delden et al.   ATHEROSCLEROSIS

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

(2017) Ajay Gupta et al.   LANCET

Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesClinical Perspective

(2016) David Nanchen et al.   CIRCULATION

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study

(2016) Dean G. Karalis et al.   Journal of Clinical Lipidology

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia

(2016) Leopoldo Perez de Isla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

(2014) K. K. Ray et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

(2013) Gerald F. Watts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

ESC/EAS Guidelines for the management of dyslipidaemias

(2011) Alberico L. Catapano et al.   ATHEROSCLEROSIS

Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence

(2011) G. Vashitz et al.   FAMILY PRACTICE

Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

(2011) Jennifer G. Robinson et al.   Journal of Clinical Lipidology

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands

(2009) A.H. Pijlman et al.   ATHEROSCLEROSIS